Meeting
2022 ASCO Annual Meeting
Emotion and symptom-focused engagement (EASE): A multisite randomized controlled trial of an intervention for individuals with acute leukemia.
Authors
Kyle Fitzgibbon
Princess Margaret Cancer Centre - UHN, Toronto, ON, Canada
Kyle Fitzgibbon , Carmine Malfitano , Anne Rydall , Breffni Hannon , Harriet Richardson , Aaron David Schimmer , Camilla Zimmermann , Gary Rodin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Acute Leukemia
Clinical Trial Registration Number
NCT04224974
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS7072)
DOI
10.1200/JCO.2022.40.16_suppl.TPS7072
Abstract #
TPS7072
Poster Bd #
298b
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Emotion and Symptom-focused Engagement (EASE): A randomized pilot trial of an integrated psychosocial and palliative care intervention for individuals with acute leukemia (AL).
First Author: Gary Rodin
Poster
2023 ASCO Quality Care Symposium
Enhancing cancer care: Leveraging technology for proactive psychosocial and social determinants of health screenings.
First Author: Mark Liu
Poster
2023 ASCO Annual Meeting
Facilitating the transition to posttreatment survivorship for adolescent and young adults: A randomized waitlist control trial of a virtual mind-body intervention.
First Author: Giselle Katiria Perez
Poster
2022 ASCO Quality Care Symposium
Oncologist-reported frequency of managing specific long-term and late effects in breast cancer survivors.
First Author: Eden Brauer